GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
20 hedge funds and large institutions have $4.24M invested in Amplify Treatments, Testing and Advancements ETF in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+13
Holders Change %
+185.71%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.31M |
2 |
Goldman Sachs
New York
|
+$809K |
3 |
Jane Street
New York
|
+$742K |
4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$432K |
5 |
Citadel Advisors
Miami,
Florida
|
+$213K |